Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine if prolonged administration of the anti TNF (tumor necrosis factor)-Alpha agent etanercept is associated with enhanced graft survival in patients undergoing i...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Virginia Commonwealth University
Collaborators
NCT07224321 · Type 1 Diabetes Mellitus
NCT06474598 · Type 1 Diabetes Mellitus
NCT07051005 · Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus (T2DM)
NCT07461805 · Type 1 Diabetes Mellitus
NCT02734277 · Type 1 Diabetes Mellitus, T1DM, and more
Virginia Commonwealth University Health System
Richmond, Virginia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions